| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |